secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ceribell, Inc. (CBLL)
CIK:        0001861107
Form:       8-K
Filed at:   2026-08-10T20:27:00+00:00
Accession:  0001193125-26-342463
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ceribell Q2 revenue up 33% to $28.1M; raises FY2026 guidance to $114-117M
-------------------------------------------------------------------------

- Total revenue $28.1M, up 33% YoY; product revenue $21.2M, subscription $6.9M.
- Net loss $19.3M ($0.51/share) vs $13.6M loss YoY; adjusted EBITDA loss $9.8M.
- Gross margin 92% (up from 88%) on cost cuts, Vietnam line, and tariff refunds.
- New $60M credit facility (term loan + revolver) refinances debt; cash $129.3M.
- Raised FY2026 revenue guidance to $114-117M (28-31% growth); FDA clearances for algorithms and hardware.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861107/000119312526342463/0001193125-26-342463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861107/000119312526342463/cbll-20260810.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-342463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer